Philips, JNJ Invest In Gilde’s €250m Healthcare Fund
This article was originally published in Clinica
The Gilde Healthcare IV later stage and growth capital fund has closed, having raised a €250m million. The new fund, which was oversubscribed, is targeting investment opportunities in medtech, digital health and therapeutics both in Europe and the US.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.